Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers

18Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The role of several risk factors, such as pollution, consumption of alcohol, age, sex and obesity in cancer progression is undeniable. Human malignancies are mainly characterized by deregulation of cyclin-dependent kinases (CDK) and cyclin inhibitor kinases (CIK) activities. Viruses express some onco-proteins which could interfere with CDK and CIKs function, and induce some signals to replicate their genome into host's cells. By reviewing some studies about the function of CDK and CIKs in cells infected with oncoviruses, such as HPV, HTLV, HERV, EBV, KSHV, HBV and HCV, we reviewed the mechanisms of different onco-proteins which could deregulate the cell cycle proteins.

Author supplied keywords

Cite

CITATION STYLE

APA

Tavakolian, S., Goudarzi, H., & Faghihloo, E. (2020, May 1). Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers. Infectious Agents and Cancer. BioMed Central Ltd. https://doi.org/10.1186/s13027-020-00295-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free